Evaluation of synthetic oligonucleotides as inhibitors of West Nile virus replication.
Identifieur interne : 002266 ( PubMed/Corpus ); précédent : 002265; suivant : 002267Evaluation of synthetic oligonucleotides as inhibitors of West Nile virus replication.
Auteurs : Paul F. Torrence ; Nidhi Gupta ; Carol Whitney ; John D. MorreySource :
- Antiviral research [ 0166-3542 ] ; 2006.
English descriptors
- KwdEn :
- MESH :
- chemical , genetics : Oligonucleotides, Antisense.
- chemical , pharmacology : Oligonucleotides, Antisense.
- drug effects : Virus Replication, West Nile virus.
- genetics : Virus Replication, West Nile virus.
- physiology : West Nile virus.
- Animals, Chlorocebus aethiops, Vero Cells.
Abstract
A series of synthetic oligonucleotide phosphorothioate 15-mers were generated against specific sequences in the West Nile virus RNA genome. These antisense oligonucleotides targeted (1) conserved features of the West Nile virus RNA genome that may be expected to lead to inhibition of virus replication since such features play essential roles in the virus lifecycle; (2) G-quartet oligonucleotides with potential facilitated uptake properties and that also targeted conserved sequences among a range of West Nile virus strains. Several formulations with significant in vitro antiviral activity were found. Among the active oligonucleotides were examples that targeted both C-rich RNA sequences of the West Nile RNA genome as well as recognized conserved sequences key to West Nile virus replication. Since the antiviral activity of the latter oligonucleotides diminished upon 2'-O-methyl substitution, it is likely that their activity involves RNase H-catalyzed RNA degradation. One G-rich oligonucleotide that did not target a West Nile virus RNA sequence also was found. These results suggest the potential of antisense strategies for the control of West Nile virus replication if the attendant problem of oligonucleotide delivery can be adequately addressed.
DOI: 10.1016/j.antiviral.2006.01.008
PubMed: 16540182
Links to Exploration step
pubmed:16540182Le document en format XML
<record><TEI><teiHeader><fileDesc><titleStmt><title xml:lang="en">Evaluation of synthetic oligonucleotides as inhibitors of West Nile virus replication.</title>
<author><name sortKey="Torrence, Paul F" sort="Torrence, Paul F" uniqKey="Torrence P" first="Paul F" last="Torrence">Paul F. Torrence</name>
<affiliation><nlm:affiliation>Northern Arizona University, Department of Chemistry and Biochemistry, Bldg 20, Room 125, Box 5698, Flagstaff, AZ 86011, USA. Paul.Torrence@nau.edu</nlm:affiliation>
</affiliation>
</author>
<author><name sortKey="Gupta, Nidhi" sort="Gupta, Nidhi" uniqKey="Gupta N" first="Nidhi" last="Gupta">Nidhi Gupta</name>
</author>
<author><name sortKey="Whitney, Carol" sort="Whitney, Carol" uniqKey="Whitney C" first="Carol" last="Whitney">Carol Whitney</name>
</author>
<author><name sortKey="Morrey, John D" sort="Morrey, John D" uniqKey="Morrey J" first="John D" last="Morrey">John D. Morrey</name>
</author>
</titleStmt>
<publicationStmt><idno type="wicri:source">PubMed</idno>
<date when="2006">2006</date>
<idno type="RBID">pubmed:16540182</idno>
<idno type="pmid">16540182</idno>
<idno type="doi">10.1016/j.antiviral.2006.01.008</idno>
<idno type="wicri:Area/PubMed/Corpus">002266</idno>
<idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Corpus" wicri:corpus="PubMed">002266</idno>
</publicationStmt>
<sourceDesc><biblStruct><analytic><title xml:lang="en">Evaluation of synthetic oligonucleotides as inhibitors of West Nile virus replication.</title>
<author><name sortKey="Torrence, Paul F" sort="Torrence, Paul F" uniqKey="Torrence P" first="Paul F" last="Torrence">Paul F. Torrence</name>
<affiliation><nlm:affiliation>Northern Arizona University, Department of Chemistry and Biochemistry, Bldg 20, Room 125, Box 5698, Flagstaff, AZ 86011, USA. Paul.Torrence@nau.edu</nlm:affiliation>
</affiliation>
</author>
<author><name sortKey="Gupta, Nidhi" sort="Gupta, Nidhi" uniqKey="Gupta N" first="Nidhi" last="Gupta">Nidhi Gupta</name>
</author>
<author><name sortKey="Whitney, Carol" sort="Whitney, Carol" uniqKey="Whitney C" first="Carol" last="Whitney">Carol Whitney</name>
</author>
<author><name sortKey="Morrey, John D" sort="Morrey, John D" uniqKey="Morrey J" first="John D" last="Morrey">John D. Morrey</name>
</author>
</analytic>
<series><title level="j">Antiviral research</title>
<idno type="ISSN">0166-3542</idno>
<imprint><date when="2006" type="published">2006</date>
</imprint>
</series>
</biblStruct>
</sourceDesc>
</fileDesc>
<profileDesc><textClass><keywords scheme="KwdEn" xml:lang="en"><term>Animals</term>
<term>Chlorocebus aethiops</term>
<term>Oligonucleotides, Antisense (genetics)</term>
<term>Oligonucleotides, Antisense (pharmacology)</term>
<term>Vero Cells</term>
<term>Virus Replication (drug effects)</term>
<term>Virus Replication (genetics)</term>
<term>West Nile virus (drug effects)</term>
<term>West Nile virus (genetics)</term>
<term>West Nile virus (physiology)</term>
</keywords>
<keywords scheme="MESH" type="chemical" qualifier="genetics" xml:lang="en"><term>Oligonucleotides, Antisense</term>
</keywords>
<keywords scheme="MESH" type="chemical" qualifier="pharmacology" xml:lang="en"><term>Oligonucleotides, Antisense</term>
</keywords>
<keywords scheme="MESH" qualifier="drug effects" xml:lang="en"><term>Virus Replication</term>
<term>West Nile virus</term>
</keywords>
<keywords scheme="MESH" qualifier="genetics" xml:lang="en"><term>Virus Replication</term>
<term>West Nile virus</term>
</keywords>
<keywords scheme="MESH" qualifier="physiology" xml:lang="en"><term>West Nile virus</term>
</keywords>
<keywords scheme="MESH" xml:lang="en"><term>Animals</term>
<term>Chlorocebus aethiops</term>
<term>Vero Cells</term>
</keywords>
</textClass>
</profileDesc>
</teiHeader>
<front><div type="abstract" xml:lang="en">A series of synthetic oligonucleotide phosphorothioate 15-mers were generated against specific sequences in the West Nile virus RNA genome. These antisense oligonucleotides targeted (1) conserved features of the West Nile virus RNA genome that may be expected to lead to inhibition of virus replication since such features play essential roles in the virus lifecycle; (2) G-quartet oligonucleotides with potential facilitated uptake properties and that also targeted conserved sequences among a range of West Nile virus strains. Several formulations with significant in vitro antiviral activity were found. Among the active oligonucleotides were examples that targeted both C-rich RNA sequences of the West Nile RNA genome as well as recognized conserved sequences key to West Nile virus replication. Since the antiviral activity of the latter oligonucleotides diminished upon 2'-O-methyl substitution, it is likely that their activity involves RNase H-catalyzed RNA degradation. One G-rich oligonucleotide that did not target a West Nile virus RNA sequence also was found. These results suggest the potential of antisense strategies for the control of West Nile virus replication if the attendant problem of oligonucleotide delivery can be adequately addressed.</div>
</front>
</TEI>
<pubmed><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">16540182</PMID>
<DateCompleted><Year>2006</Year>
<Month>08</Month>
<Day>04</Day>
</DateCompleted>
<DateRevised><Year>2019</Year>
<Month>12</Month>
<Day>10</Day>
</DateRevised>
<Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Print">0166-3542</ISSN>
<JournalIssue CitedMedium="Print"><Volume>70</Volume>
<Issue>2</Issue>
<PubDate><Year>2006</Year>
<Month>Jun</Month>
</PubDate>
</JournalIssue>
<Title>Antiviral research</Title>
<ISOAbbreviation>Antiviral Res.</ISOAbbreviation>
</Journal>
<ArticleTitle>Evaluation of synthetic oligonucleotides as inhibitors of West Nile virus replication.</ArticleTitle>
<Pagination><MedlinePgn>60-5</MedlinePgn>
</Pagination>
<Abstract><AbstractText>A series of synthetic oligonucleotide phosphorothioate 15-mers were generated against specific sequences in the West Nile virus RNA genome. These antisense oligonucleotides targeted (1) conserved features of the West Nile virus RNA genome that may be expected to lead to inhibition of virus replication since such features play essential roles in the virus lifecycle; (2) G-quartet oligonucleotides with potential facilitated uptake properties and that also targeted conserved sequences among a range of West Nile virus strains. Several formulations with significant in vitro antiviral activity were found. Among the active oligonucleotides were examples that targeted both C-rich RNA sequences of the West Nile RNA genome as well as recognized conserved sequences key to West Nile virus replication. Since the antiviral activity of the latter oligonucleotides diminished upon 2'-O-methyl substitution, it is likely that their activity involves RNase H-catalyzed RNA degradation. One G-rich oligonucleotide that did not target a West Nile virus RNA sequence also was found. These results suggest the potential of antisense strategies for the control of West Nile virus replication if the attendant problem of oligonucleotide delivery can be adequately addressed.</AbstractText>
</Abstract>
<AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Torrence</LastName>
<ForeName>Paul F</ForeName>
<Initials>PF</Initials>
<AffiliationInfo><Affiliation>Northern Arizona University, Department of Chemistry and Biochemistry, Bldg 20, Room 125, Box 5698, Flagstaff, AZ 86011, USA. Paul.Torrence@nau.edu</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y"><LastName>Gupta</LastName>
<ForeName>Nidhi</ForeName>
<Initials>N</Initials>
</Author>
<Author ValidYN="Y"><LastName>Whitney</LastName>
<ForeName>Carol</ForeName>
<Initials>C</Initials>
</Author>
<Author ValidYN="Y"><LastName>Morrey</LastName>
<ForeName>John D</ForeName>
<Initials>JD</Initials>
</Author>
</AuthorList>
<Language>eng</Language>
<PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType>
<PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType>
</PublicationTypeList>
<ArticleDate DateType="Electronic"><Year>2006</Year>
<Month>02</Month>
<Day>13</Day>
</ArticleDate>
</Article>
<MedlineJournalInfo><Country>Netherlands</Country>
<MedlineTA>Antiviral Res</MedlineTA>
<NlmUniqueID>8109699</NlmUniqueID>
<ISSNLinking>0166-3542</ISSNLinking>
</MedlineJournalInfo>
<ChemicalList><Chemical><RegistryNumber>0</RegistryNumber>
<NameOfSubstance UI="D016376">Oligonucleotides, Antisense</NameOfSubstance>
</Chemical>
</ChemicalList>
<CitationSubset>IM</CitationSubset>
<MeshHeadingList><MeshHeading><DescriptorName UI="D000818" MajorTopicYN="N">Animals</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D002522" MajorTopicYN="N">Chlorocebus aethiops</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D016376" MajorTopicYN="N">Oligonucleotides, Antisense</DescriptorName>
<QualifierName UI="Q000235" MajorTopicYN="Y">genetics</QualifierName>
<QualifierName UI="Q000494" MajorTopicYN="Y">pharmacology</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D014709" MajorTopicYN="N">Vero Cells</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D014779" MajorTopicYN="N">Virus Replication</DescriptorName>
<QualifierName UI="Q000187" MajorTopicYN="Y">drug effects</QualifierName>
<QualifierName UI="Q000235" MajorTopicYN="Y">genetics</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D014902" MajorTopicYN="N">West Nile virus</DescriptorName>
<QualifierName UI="Q000187" MajorTopicYN="N">drug effects</QualifierName>
<QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName>
<QualifierName UI="Q000502" MajorTopicYN="Y">physiology</QualifierName>
</MeshHeading>
</MeshHeadingList>
</MedlineCitation>
<PubmedData><History><PubMedPubDate PubStatus="received"><Year>2005</Year>
<Month>08</Month>
<Day>18</Day>
</PubMedPubDate>
<PubMedPubDate PubStatus="revised"><Year>2006</Year>
<Month>01</Month>
<Day>11</Day>
</PubMedPubDate>
<PubMedPubDate PubStatus="accepted"><Year>2006</Year>
<Month>01</Month>
<Day>11</Day>
</PubMedPubDate>
<PubMedPubDate PubStatus="pubmed"><Year>2006</Year>
<Month>3</Month>
<Day>17</Day>
<Hour>9</Hour>
<Minute>0</Minute>
</PubMedPubDate>
<PubMedPubDate PubStatus="medline"><Year>2006</Year>
<Month>8</Month>
<Day>5</Day>
<Hour>9</Hour>
<Minute>0</Minute>
</PubMedPubDate>
<PubMedPubDate PubStatus="entrez"><Year>2006</Year>
<Month>3</Month>
<Day>17</Day>
<Hour>9</Hour>
<Minute>0</Minute>
</PubMedPubDate>
</History>
<PublicationStatus>ppublish</PublicationStatus>
<ArticleIdList><ArticleId IdType="pubmed">16540182</ArticleId>
<ArticleId IdType="pii">S0166-3542(06)00027-1</ArticleId>
<ArticleId IdType="doi">10.1016/j.antiviral.2006.01.008</ArticleId>
</ArticleIdList>
</PubmedData>
</pubmed>
</record>
Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Sante/explor/MersV1/Data/PubMed/Corpus
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 002266 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/PubMed/Corpus/biblio.hfd -nk 002266 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien |wiki= Sante |area= MersV1 |flux= PubMed |étape= Corpus |type= RBID |clé= pubmed:16540182 |texte= Evaluation of synthetic oligonucleotides as inhibitors of West Nile virus replication. }}
Pour générer des pages wiki
HfdIndexSelect -h $EXPLOR_AREA/Data/PubMed/Corpus/RBID.i -Sk "pubmed:16540182" \ | HfdSelect -Kh $EXPLOR_AREA/Data/PubMed/Corpus/biblio.hfd \ | NlmPubMed2Wicri -a MersV1
This area was generated with Dilib version V0.6.33. |